Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury.

Burnside ER, De Winter F, Didangelos A, James ND, Andreica EC, Layard-Horsfall H, Muir EM, Verhaagen J, Bradbury EJ.

Brain. 2018 Jun 14. doi: 10.1093/brain/awy158. [Epub ahead of print]

PMID:
29912283
2.

Transplantation of canine olfactory ensheathing cells producing chondroitinase ABC promotes chondroitin sulphate proteoglycan digestion and axonal sprouting following spinal cord injury.

Carwardine D, Prager J, Neeves J, Muir EM, Uney J, Granger N, Wong LF.

PLoS One. 2017 Dec 11;12(12):e0188967. doi: 10.1371/journal.pone.0188967. eCollection 2017.

3.

Electrospun silk-polyaniline conduits for functional nerve regeneration in rat sciatic nerve injury model.

Das S, Sharma M, Saharia D, Sarma KK, Muir EM, Bora U.

Biomed Mater. 2017 Aug 17;12(4):045025. doi: 10.1088/1748-605X/aa7802.

PMID:
28632137
4.

Canine olfactory ensheathing cells from the olfactory mucosa can be engineered to produce active chondroitinase ABC.

Carwardine D, Wong LF, Fawcett JW, Muir EM, Granger N.

J Neurol Sci. 2016 Aug 15;367:311-8. doi: 10.1016/j.jns.2016.06.011. Epub 2016 Jun 4.

PMID:
27423610
5.

Chondroitinase gene therapy improves upper limb function following cervical contusion injury.

James ND, Shea J, Muir EM, Verhaagen J, Schneider BL, Bradbury EJ.

Exp Neurol. 2015 Sep;271:131-5. doi: 10.1016/j.expneurol.2015.05.022. Epub 2015 Jun 1.

6.

Large-scale chondroitin sulfate proteoglycan digestion with chondroitinase gene therapy leads to reduced pathology and modulates macrophage phenotype following spinal cord contusion injury.

Bartus K, James ND, Didangelos A, Bosch KD, Verhaagen J, Yáñez-Muñoz RJ, Rogers JH, Schneider BL, Muir EM, Bradbury EJ.

J Neurosci. 2014 Apr 2;34(14):4822-36. doi: 10.1523/JNEUROSCI.4369-13.2014.

7.

AAV vector-mediated secretion of chondroitinase provides a sensitive tracer for axonal arborisations.

Alves JN, Muir EM, Andrews MR, Ward A, Michelmore N, Dasgupta D, Verhaagen J, Moloney EB, Keynes RJ, Fawcett JW, Rogers JH.

J Neurosci Methods. 2014 Apr 30;227:107-20. doi: 10.1016/j.jneumeth.2014.02.010. Epub 2014 Feb 28.

PMID:
24583077
8.

Combination of engineered Schwann cell grafts to secrete neurotrophin and chondroitinase promotes axonal regeneration and locomotion after spinal cord injury.

Kanno H, Pressman Y, Moody A, Berg R, Muir EM, Rogers JH, Ozawa H, Itoi E, Pearse DD, Bunge MB.

J Neurosci. 2014 Jan 29;34(5):1838-55. doi: 10.1523/JNEUROSCI.2661-13.2014.

9.

Lentiviral vectors express chondroitinase ABC in cortical projections and promote sprouting of injured corticospinal axons.

Zhao RR, Muir EM, Alves JN, Rickman H, Allan AY, Kwok JC, Roet KC, Verhaagen J, Schneider BL, Bensadoun JC, Ahmed SG, Yáñez-Muñoz RJ, Keynes RJ, Fawcett JW, Rogers JH.

J Neurosci Methods. 2011 Sep 30;201(1):228-38. doi: 10.1016/j.jneumeth.2011.08.003. Epub 2011 Aug 9.

10.

Modification of N-glycosylation sites allows secretion of bacterial chondroitinase ABC from mammalian cells.

Muir EM, Fyfe I, Gardiner S, Li L, Warren P, Fawcett JW, Keynes RJ, Rogers JH.

J Biotechnol. 2010 Jan 15;145(2):103-10. doi: 10.1016/j.jbiotec.2009.11.002. Epub 2009 Nov 10.

11.

Effects of Schwann cell transplants in an experimental nerve amputee model.

Lago N, Casas C, Muir EM, Rogers J, Navarro X.

Restor Neurol Neurosci. 2009;27(1):67-78. doi: 10.3233/RNN-2009-0462.

PMID:
19164854
12.

Transplantation of Schwann cell line clones secreting GDNF or BDNF into the retinas of dystrophic Royal College of Surgeons rats.

Lawrence JM, Keegan DJ, Muir EM, Coffey PJ, Rogers JH, Wilby MJ, Fawcett JW, Lund RD.

Invest Ophthalmol Vis Sci. 2004 Jan;45(1):267-74.

PMID:
14691183
13.

A herpesvirus vector can transduce axotomized brain neurons.

Rogers JH, Rhodes K, Roberts S, Raza M, Muir EM, Fawcett JW, Scarpini CG, Efstathiou S.

Exp Neurol. 2003 Oct;183(2):548-58.

PMID:
14552896
14.

Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes.

Muir EM, Adcock KH, Morgenstern DA, Clayton R, von Stillfried N, Rhodes K, Ellis C, Fawcett JW, Rogers JH.

Brain Res Mol Brain Res. 2002 Apr 30;100(1-2):103-17.

PMID:
12008026
15.

Green fluorescent protein as a quantitative tool.

Hack NJ, Billups B, Guthrie PB, Rogers JH, Muir EM, Parks TN, Kater SB.

J Neurosci Methods. 2000 Feb 15;95(2):177-84.

PMID:
10752489
16.

Distribution of the receptor EphA7 and its ligands in development of the mouse nervous system.

Rogers JH, Ciossek T, Ullrich A, West E, Hoare M, Muir EM.

Brain Res Mol Brain Res. 1999 Dec 10;74(1-2):225-30.

PMID:
10640695
17.

N-Cadherin inhibits Schwann cell migration on astrocytes.

Wilby MJ, Muir EM, Fok-Seang J, Gour BJ, Blaschuk OW, Fawcett JW.

Mol Cell Neurosci. 1999 Jul;14(1):66-84.

PMID:
10433818
18.
19.

Functional and anatomical reconstruction of the 6-hydroxydopamine lesioned nigrostriatal system of the adult rat.

Brecknell JE, Haque NS, Du JS, Muir EM, Fidler PS, Hlavin ML, Fawcett JW, Dunnett SB.

Neuroscience. 1996 Apr;71(4):913-25.

PMID:
8684622
20.

T-cell epitope analysis using subtracted expression libraries (TEASEL): application to a 38-kDA autoantigen recognized by T cells from an insulin-dependent diabetic patient.

Neophytou PI, Roep BO, Arden SD, Muir EM, Duinkerken G, Kallan A, de Vries RR, Hutton JC.

Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2014-8.

21.
22.

Calbindin D28K expression in transfected mouse NIH3T3 cells.

Muir EM, Lawson DE, Sepúlveda FV, O'Brien JA, Harding M.

Cell Calcium. 1993 Apr;14(4):349-58.

PMID:
8370070
25.

Modification of the rate of pinocytosis in arterial smooth muscle cells in culture.

Leake DS, Muir EM, Bowyer DE.

Exp Mol Pathol. 1982 Apr;36(2):262-75. No abstract available.

PMID:
6174369

Supplemental Content

Support Center